Evommune Inc. share price logo

Evommune Inc.

NASDAQ: EVMN

Small Cap

$25.18

+1.05

(+4.35%)

as on

Evommune Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $23.91
    $25.87
    downward going graph

    5.04%

    Downside

    2.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Evommune Inc. share price movements today

Previous Close
$24.13
Open
$24.50
Volume
739.8K
Day's Low - High
$23.91 - $25.87

Evommune Inc. Historical Returns

1 Month Return
+ 3.34 %
3 Month Return
+ 1.94 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Evommune Inc. Stock Fundamentals & Key Indicators

Check Evommune Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$875.8M

EPS (TTM)

-2.7556

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-44.95%

Evommune Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evommune Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Evommune Inc. image
Evommune Inc.
NA$875.8MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$39.3B67.15%74.0712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.6B147.08%28.1735.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B12.64%15.2229.65%0.58%

Evommune Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Sep 2024
Dec 2024
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
7
-
-
3
10
-
-
Gross Profit
6
-
-
2
10
0
0
Operating Income
-3
-16
-18
-15
-13
-29
-23
EBITDA
-2
-
-17
-14
-12
-27
-21
Interest Expense
0
-
-
0
-
-
-
Depreciation
-
0
0
-
0
0
0
Income Before Tax
-2
-15
-18
-14
-12
-28
-21
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-2
-15
-18
-14
-12
-28
-21
Net Profit Margin
-39.77%
0.00%
0.00%
-485.23%
-124.75%
0.00%
0.00%

Evommune Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
7
13
Gross Profit
4
5
13
Operating Income
-37
-70
-81
EBITDA
-32
-65
-67
Interest Expense
0
0
0
Depreciation
-
-
1
Income Before Tax
-34
-66
-68
Income Tax Expense
-
-
-
Net Income
-34
-66
-68
Net Profit Margin
-681.06%
-954.40%
-529.77%

Evommune Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-27
-15
-18
-14
-13
-12
-28
-21
Operating Cash Flow
-8
-26
-22
-23
-26
-9
-16
-27
Investing Cash Flow
10
-
-11
13
18
-23
-122
-85
Financing Cash Flow
0
0
24
0
64
0
156
117
Change in Cash
1
-16
-1
5
56
-35
17
4

Evommune Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2024
Dec 2025
Net Income
-66
-68
Operating Cash Flow
-58
-76
Investing Cash Flow
-3
-115
Financing Cash Flow
49
220
Change in Cash
-12
27

Global Institutional Holdings in Evommune Inc.

Funds
Holdings
Baker Bros Advisors LP
2.35%
Defilade Capital Management, L.P.
1.88%
Kynam Capital Management, LP
1.74%
Pivotal bioVenture Partners Investment Advisor LLC
5.35%
RTW INVESTMENTS, LLC
4.17%
See all

Insights on Evommune Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, EVMN stock has moved up by 17.9%

About Evommune Inc.

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
OrganisationEvommune Inc.
Headquarters1891 Page Mill Road, Palo Alto, CA, United States, 94304
IndustryBiotechnology
CEOMr. Luis C. Pena
E-voting on sharesClick here to vote

Key Management of Evommune Inc.

Name

Title

Mr. Luis C. Pena

Founder, President, CEO & Director

Mr. Kyle Carver CPA, M.B.A.

Chief Financial Officer

Dr. Jeegar Patel Ph.D.

Chief Scientific Officer

Ms. Janice Drew M.P.H.

Chief of Development Operations

Dr. Daniel J. Burge M.d.

Senior Vice President of Clinical Development

Mr. J. Mark Jackson M.D.

Senior Vice President of Clinical Development

Mr. Gregory S. Moss Esq.

Chief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer

Dr. Eugene Andrew Bauer M.D.

Co-Founder, Chief Medical Officer & Director

Dr. Lou Sehl Ph.D.

Senior Vice President of Technical Operations

FAQs

What is Evommune Inc. share price today?

Evommune Inc. share price today is $25.18 as on at the close of the market. Evommune Inc. share today touched a day high of $25.87 and a low of $23.91.

What is the 52 week high and 52 week low for Evommune Inc. share?

Evommune Inc. share touched a 52 week high of $0 on and a 52 week low of $0 on . Evommune Inc. stock price today i.e. is closed at $25.18,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Evommune Inc.'s market capitalisation today?

Evommune Inc. market capitalisation is $0.00T as on .

How to invest in Evommune Inc. Stock (EVMN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evommune Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evommune Inc. Shares that will get you 0.0596 shares as per Evommune Inc. share price of $25.18 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Evommune Inc. Stock (EVMN) from India?

Indian investors can start investing in Evommune Inc. (EVMN) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Evommune Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Evommune Inc. share’s latest price of $25.18 as on June 27, 2026 at 8:46 am IST, you will get 0.3971 shares of Evommune Inc.. Learn more about fractional shares .